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ABSTRACT 
Amniotic fluid (AF) is now known to harbor highly potent stem cells, making it an excellent 
source for cell therapy. However, most of the stem cells isolated are from AF of mid-term 
pregnancies in which the collection procedure involves an invasive technique termed 
amniocentesis. This has limited the access in getting the fluid as the technique imposes 
certain level of risks to the mother as well as to the fetus. Alternatively, getting AF from full-
term pregnancies or during deliveries would be a better resolution. Unfortunately, very few 
studies have isolated stem cells from AF at this stage of gestation, the fluid that is merely 
discarded during delivery. The question remains whether full-term AF harbors stem cells of 
similar potency as of the stem cells of mid-term AF. Here, we aim to review the prospect of 
having this type of stem cells by first looking at the origin and contents of AF particularly 
during different gestation period. We will then discuss the possibility that the AF, at full term, 
contains a population of highly potent stem cells. These stem cells are distinct from, and 
probably more potent than the AF mesenchymal stem cells (AF-MSCs) isolated from full-
term AF. By comparing the studies on stem cells isolated from mid-term versus full-term AF 
from various species, we intend to address the prospect of having highly potent amniotic fluid 
stem cells from AF of full-term pregnancies in human and animals. 
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